There is strong evidence that GAPDH can interact with β-amyloid and huntingtin proteins to regulate their cytotoxicity, thus directly linking to several neurodegenerative disorders, such as Alzheimer’s, Huntington’s, and Parkinson’s diseases (Colell et al, 2009). This evidence concerns the gene GAPDH and Parkinson disease.